| Kathleen Lea, CCC-A | |
|
1199 Haley Center, Auburn, AL 36849-1931 | |
| (344) 844-9600 | |
| (334) 844-9684 |
| Full Name | Kathleen Lea |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 1199 Haley Center, Auburn, Alabama |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922196039 | NPI | - | NPPES |
| 737441936A | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AUD003628 (Georgia) | Primary |
| Provider Name | Auburn University |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1235316753 PECOS PAC ID: 2365735750 Enrollment ID: O20160722001064 |
News Archive
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). BLISS-76 study results through 52 weeks showed that belimumab 10 mg/kg plus standard of care achieved a statistically significant improvement in patient response rate as measured by the SLE Responder Index at Week 52, compared with placebo plus standard of care.
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced three upcoming data presentations for it Ultrafast Insulin programs at the American Diabetes Association (ADA) 71st Scientific Sessions taking place June 24-28, 2011 at the San Diego Convention Center.
Obesity is more prevalent in areas with lower educational attainment and certain ethnic profiles than in areas of suburban sprawl, according to researchers at the University of Illinois at Chicago.
The Global Genes Project (www.globalgenesproject.org), today announced that its rare disease campaign slogan, "Hope – It's In Our Genes™," has been translated into multiple international languages and Braille by rare disease patient advocates and supporters from around the world. The translation of this slogan unifies the rare disease community and global network under one banner.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Lea, CCC-A 1199 Haley Center, Auburn, AL 36849-0001 Ph: (334) 844-9600 | Kathleen Lea, CCC-A 1199 Haley Center, Auburn, AL 36849-1931 Ph: (344) 844-9600 |
News Archive
Human Genome Sciences, Inc. and GlaxoSmithKline PLC (GSK) today announced that BENLYSTA™ (belimumab) met the primary endpoint in BLISS-76, the second of two pivotal Phase 3 trials in seropositive patients with systemic lupus erythematosus (SLE). BLISS-76 study results through 52 weeks showed that belimumab 10 mg/kg plus standard of care achieved a statistically significant improvement in patient response rate as measured by the SLE Responder Index at Week 52, compared with placebo plus standard of care.
The national Tourette Syndrome Association and Psyadon Pharmaceuticals Inc. are pleased to announce their collaboration on a clinical trial to determine the potential efficacy of a novel drug, ecopipam, for managing the symptoms of the neurological disorder Tourette Syndrome.
Halozyme Therapeutics, Inc., a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced three upcoming data presentations for it Ultrafast Insulin programs at the American Diabetes Association (ADA) 71st Scientific Sessions taking place June 24-28, 2011 at the San Diego Convention Center.
Obesity is more prevalent in areas with lower educational attainment and certain ethnic profiles than in areas of suburban sprawl, according to researchers at the University of Illinois at Chicago.
The Global Genes Project (www.globalgenesproject.org), today announced that its rare disease campaign slogan, "Hope – It's In Our Genes™," has been translated into multiple international languages and Braille by rare disease patient advocates and supporters from around the world. The translation of this slogan unifies the rare disease community and global network under one banner.
› Verified 2 days ago
Dr. Hannah Elizabeth Hoven, AU.D., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2415 Moores Mill Rd, Suite 225, Auburn, AL 36830 Phone: 334-521-7501 Fax: 334-323-9573 | |
Dr. Page Parker Cresawn, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2245 Springwood Dr, Auburn, AL 36830 Phone: 334-477-6998 | |
Homestead Hearing Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2245 Springwood Dr, Auburn, AL 36830 Phone: 334-748-8254 | |
Charles Cresawn, AU.D Audiologist Medicare: Accepting Medicare Assignments Practice Location: 2245 Springwood Dr, Auburn, AL 36830 Phone: 706-326-6357 | |
Dr. Aurora Juliet Weaver, AU.D Audiologist Medicare: Medicare Enrolled Practice Location: 1199 Haley Center, Auburn, AL 36849 Phone: 334-844-9600 Fax: 334-844-9684 | |
Dr. Shandi L Dabbs, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 2290 Moores Mill Rd, Suite 400, Auburn, AL 36830 Phone: 706-518-8501 | |
Hearing Professionals Of Alabama Audiologist Medicare: Medicare Enrolled Practice Location: 2415 Moores Mill Rd, Suite 225, Auburn, AL 36830 Phone: 251-769-0599 |